The Kara Goldin Show avatar

Dexa/The Kara Goldin Show

Learn more
Published Nov 11, 2020

98 Paula Schneider: President & CEO of Susan G. Komen

Join Paula Schneider as she shares her journey from fashion executive to the President and CEO of Susan G. Komen, driven by a personal connection to breast cancer and a commitment to innovation in treatment and advocacy for improved patient outcomes.
Episode Highlights
The Kara Goldin Show logo

Topics covered

Popular Clips

Episode Highlights

  • Research Focus

    Susan G. Komen's research initiatives are pivotal in the fight against breast cancer, focusing on curing the disease and preventing metastasis. emphasizes the importance of funding, stating that "cash cures cancer" as it sustains the researchers dedicated to this cause 1. The organization has redirected its research dollars towards metastatic breast cancer, which is the primary cause of mortality. Currently, they are conducting 254 research projects, including a promising clinical trial for hormone receptor-positive, HER2-negative patients 1.

       

    Immunotherapy

    Immunotherapy is emerging as a groundbreaking treatment for triple-negative breast cancer, one of the most challenging types to treat. Paula shares her personal connection to this research, having battled this aggressive cancer herself 2. She explains that immunotherapy works by teaching the body's immune system to combat cancer cells, leading to significant tumor reduction in patients. This advancement offers hope for those with limited treatment options, highlighting the potential of immunotherapy to transform cancer care 2.

Related Episodes